These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 33948897)
1. Examining the Potential Formation of Ternary Chromium-Histidine-DNA Complexes and Implications for Their Carcinogenicity. Lankford E; Thomas CS; Marchi S; Brown S; Woski SA; Vincent JB Biol Trace Elem Res; 2022 Mar; 200(3):1473-1481. PubMed ID: 33948897 [TBL] [Abstract][Full Text] [Related]
2. Examining the Potential Formation of Ternary DNA Complexes with Chromium‑Cysteine, Chromium-Ascorbate, and Chromium-Glutathione and Implications for Their Carcinogenicity. Marchi S; Lankford E; Dorin B; Drummond E; Thomas SC; Woski SA; Vincent JB Biol Trace Elem Res; 2023 Oct; 201(10):5053-5066. PubMed ID: 36662348 [TBL] [Abstract][Full Text] [Related]
3. Formation of the amino acid-DNA complexes by hexavalent and trivalent chromium in vitro: importance of trivalent chromium and the phosphate group. Zhitkovich A; Voitkun V; Costa M Biochemistry; 1996 Jun; 35(22):7275-82. PubMed ID: 8679557 [TBL] [Abstract][Full Text] [Related]
4. Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells. Quievryn G; Peterson E; Messer J; Zhitkovich A Biochemistry; 2003 Feb; 42(4):1062-70. PubMed ID: 12549927 [TBL] [Abstract][Full Text] [Related]
5. Reductive activation with cysteine represents a chromium(III)-dependent pathway in the induction of genotoxicity by carcinogenic chromium(VI). Zhitkovich A; Quievryn G; Messer J; Motylevich Z Environ Health Perspect; 2002 Oct; 110 Suppl 5(Suppl 5):729-31. PubMed ID: 12426121 [TBL] [Abstract][Full Text] [Related]
6. Non-oxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: role of ternary DNA adducts in Cr(III)-dependent mutagenesis. Zhitkovich A; Song Y; Quievryn G; Voitkun V Biochemistry; 2001 Jan; 40(2):549-60. PubMed ID: 11148050 [TBL] [Abstract][Full Text] [Related]
7. Cr(III)-mediated crosslinks of glutathione or amino acids to the DNA phosphate backbone are mutagenic in human cells. Voitkun V; Zhitkovich A; Costa M Nucleic Acids Res; 1998 Apr; 26(8):2024-30. PubMed ID: 9518499 [TBL] [Abstract][Full Text] [Related]
8. Sequence specificity of Cr(III)-DNA adduct formation in the p53 gene: NGG sequences are preferential adduct-forming sites. Arakawa H; Wu F; Costa M; Rom W; Tang MS Carcinogenesis; 2006 Mar; 27(3):639-45. PubMed ID: 16251206 [TBL] [Abstract][Full Text] [Related]
9. Glutathione and free amino acids form stable complexes with DNA following exposure of intact mammalian cells to chromate. Zhitkovich A; Voitkun V; Costa M Carcinogenesis; 1995 Apr; 16(4):907-13. PubMed ID: 7728973 [TBL] [Abstract][Full Text] [Related]
11. Forming a chromium-based interstrand DNA crosslink: Implications for carcinogenicity. Brown S; Marchi S; Thomas CS; Hale AR; Lockart M; Bowman MK; Christou G; Woski SA; Vincent JB J Inorg Biochem; 2024 Feb; 251():112439. PubMed ID: 38039560 [TBL] [Abstract][Full Text] [Related]
12. Chromium (VI) induces both bulky DNA adducts and oxidative DNA damage at adenines and guanines in the p53 gene of human lung cells. Arakawa H; Weng MW; Chen WC; Tang MS Carcinogenesis; 2012 Oct; 33(10):1993-2000. PubMed ID: 22791815 [TBL] [Abstract][Full Text] [Related]
13. Carcinogenic chromium(VI) induces cross-linking of vitamin C to DNA in vitro and in human lung A549 cells. Quievryn G; Messer J; Zhitkovich A Biochemistry; 2002 Mar; 41(9):3156-67. PubMed ID: 11863455 [TBL] [Abstract][Full Text] [Related]
14. Nucleotide excision repair functions in the removal of chromium-induced DNA damage in mammalian cells. O'Brien TJ; Brooks BR; Patierno SR Mol Cell Biochem; 2005 Nov; 279(1-2):85-95. PubMed ID: 16283517 [TBL] [Abstract][Full Text] [Related]
15. Disproportionation of a model chromium(V) complex causes extensive chromium(III)-DNA binding in vitro. Levina A; Lay PA; Dixon NE Chem Res Toxicol; 2001 Aug; 14(8):946-50. PubMed ID: 11511167 [TBL] [Abstract][Full Text] [Related]
16. Reductive metabolism of Cr(VI) by cysteine leads to the formation of binary and ternary Cr--DNA adducts in the absence of oxidative DNA damage. Zhitkovich A; Shrager S; Messer J Chem Res Toxicol; 2000 Nov; 13(11):1114-24. PubMed ID: 11087433 [TBL] [Abstract][Full Text] [Related]
17. Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. O'Brien TJ; Ceryak S; Patierno SR Mutat Res; 2003 Dec; 533(1-2):3-36. PubMed ID: 14643411 [TBL] [Abstract][Full Text] [Related]
18. Stability and absorption of chromium and absorption of chromium histidinate complexes by humans. Anderson RA; Polansky MM; Bryden NA Biol Trace Elem Res; 2004 Dec; 101(3):211-8. PubMed ID: 15564651 [TBL] [Abstract][Full Text] [Related]
19. Human nucleotide excision repair efficiently removes chromium-DNA phosphate adducts and protects cells against chromate toxicity. Reynolds M; Peterson E; Quievryn G; Zhitkovich A J Biol Chem; 2004 Jul; 279(29):30419-24. PubMed ID: 15087443 [TBL] [Abstract][Full Text] [Related]
20. Differential impact of ionic and coordinate covalent chromium (Cr)-DNA binding on DNA replication. Fornsaglio JL; O'Brien TJ; Patierno SR Mol Cell Biochem; 2005 Nov; 279(1-2):149-55. PubMed ID: 16283524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]